Your browser doesn't support javascript.
loading
In vitro evidence of oncofetal antigen and TLR-9 agonist co-delivery by alginate nanovaccines for liver cancer immunotherapy.
Pei, Mengyue; Li, Huiyang; Zhu, Yingwei; Lu, Jian; Zhang, Chuangnian.
Afiliación
  • Pei M; Tianjin Key Laboratory of Biomaterial Research, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, 300192, China. cnzhang@mail.nankai.edu.cn.
  • Li H; Tianjin Key Laboratory of Biomaterial Research, Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, 300192, China. cnzhang@mail.nankai.edu.cn.
  • Zhu Y; Department of Gastroenterology, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi city, 214002, China. zhuyingw2020@163.com.
  • Lu J; Department of Gastroenterology, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi city, 214002, China.
  • Zhang C; Department of Gastroenterology, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi city, 214002, China.
Biomater Sci ; 10(11): 2865-2876, 2022 May 31.
Article en En | MEDLINE | ID: mdl-35445677
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Receptor Toll-Like 9 / Nanopartículas / Neoplasias Hepáticas / Antígenos de Neoplasias Idioma: En Revista: Biomater Sci Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Receptor Toll-Like 9 / Nanopartículas / Neoplasias Hepáticas / Antígenos de Neoplasias Idioma: En Revista: Biomater Sci Año: 2022 Tipo del documento: Article País de afiliación: China